Immunodiagnostics Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2032
Description
Persistence Market Research has recently released a comprehensive report on the worldwide market for immunodiagnostics. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global immunodiagnostics market from 2025 to 2032.
Key Insights:
Immunodiagnostics involves the use of antigen-antibody interactions to detect and quantify biological markers associated with various diseases. These diagnostic techniques are widely used in clinical laboratories, hospitals, and physician offices for the detection of infectious diseases, cancer, autoimmune disorders, and hormonal imbalances. The immunodiagnostics market encompasses a range of products, including instruments, reagents, and consumables, utilizing advanced technologies such as enzyme-linked immunosorbent assay (ELISA), chemiluminescence immunoassay (CLIA), fluorescent immunoassay, and radioimmunoassay. Market growth is driven by increasing disease prevalence, rising demand for early and accurate diagnosis, and continuous advancements in diagnostic technologies.
Market Growth Drivers:
The global immunodiagnostics market is propelled by several key factors, including the increasing prevalence of infectious and chronic diseases such as cancer, cardiovascular conditions, and autoimmune disorders. Growing awareness regarding early disease detection and preventive healthcare significantly boosts demand for immunodiagnostic tests. Technological advancements, including high-throughput screening, automation, and multiplex testing, enhance diagnostic accuracy and efficiency, further driving adoption. Additionally, the expansion of healthcare infrastructure, particularly in emerging economies, and increased government initiatives for disease screening programs contribute to market growth.
Market Restraints:
Despite promising growth prospects, the immunodiagnostics market faces challenges related to high costs associated with advanced diagnostic instruments and reagents. Regulatory complexities and stringent approval processes can delay product launches and increase compliance burdens for manufacturers. Variability in test results and the need for skilled professionals to operate advanced diagnostic systems may also limit widespread adoption. Furthermore, reimbursement issues in certain regions and limited access to advanced diagnostics in low-income areas pose additional challenges to market expansion.
Market Opportunities:
The immunodiagnostics market presents significant growth opportunities driven by innovation in diagnostic technologies and the increasing adoption of personalized medicine. The development of point-of-care testing devices and rapid diagnostic kits enhances accessibility and convenience, especially in remote and resource-limited settings. Integration of artificial intelligence and data analytics in diagnostic platforms improves accuracy and clinical decision-making. Additionally, growing investments in research and development, along with strategic collaborations between diagnostic companies and healthcare providers, are expected to create new avenues for growth. Expanding applications in oncology, infectious disease surveillance, and biomarker discovery further broaden the market scope.
Key Questions Answered in the Report:
Leading players in the global immunodiagnostics market, including Abbott, Roche Diagnostics, and Thermo Fisher Scientific, focus on innovation, product differentiation, and strategic partnerships to strengthen their market position. These companies invest heavily in research and development to introduce advanced diagnostic solutions with improved sensitivity, specificity, and turnaround time. Collaborations with healthcare providers, research institutions, and government agencies support technology adoption and market expansion. Additionally, emphasis on automation, digital integration, and expanding product portfolios helps companies remain competitive in the rapidly evolving diagnostic landscape.
Key Companies Profiled:
By Product Type:
Please Note: It will take 5 business days to complete the report upon order confirmation.
Key Insights:
- Immunodiagnostics Market Size (2025E): US$ 23.4 Billion
- Projected Market Value (2032F): US$ 38.1 Billion
- Global Market Growth Rate (CAGR 2025 to 2032): 7.2%
Immunodiagnostics involves the use of antigen-antibody interactions to detect and quantify biological markers associated with various diseases. These diagnostic techniques are widely used in clinical laboratories, hospitals, and physician offices for the detection of infectious diseases, cancer, autoimmune disorders, and hormonal imbalances. The immunodiagnostics market encompasses a range of products, including instruments, reagents, and consumables, utilizing advanced technologies such as enzyme-linked immunosorbent assay (ELISA), chemiluminescence immunoassay (CLIA), fluorescent immunoassay, and radioimmunoassay. Market growth is driven by increasing disease prevalence, rising demand for early and accurate diagnosis, and continuous advancements in diagnostic technologies.
Market Growth Drivers:
The global immunodiagnostics market is propelled by several key factors, including the increasing prevalence of infectious and chronic diseases such as cancer, cardiovascular conditions, and autoimmune disorders. Growing awareness regarding early disease detection and preventive healthcare significantly boosts demand for immunodiagnostic tests. Technological advancements, including high-throughput screening, automation, and multiplex testing, enhance diagnostic accuracy and efficiency, further driving adoption. Additionally, the expansion of healthcare infrastructure, particularly in emerging economies, and increased government initiatives for disease screening programs contribute to market growth.
Market Restraints:
Despite promising growth prospects, the immunodiagnostics market faces challenges related to high costs associated with advanced diagnostic instruments and reagents. Regulatory complexities and stringent approval processes can delay product launches and increase compliance burdens for manufacturers. Variability in test results and the need for skilled professionals to operate advanced diagnostic systems may also limit widespread adoption. Furthermore, reimbursement issues in certain regions and limited access to advanced diagnostics in low-income areas pose additional challenges to market expansion.
Market Opportunities:
The immunodiagnostics market presents significant growth opportunities driven by innovation in diagnostic technologies and the increasing adoption of personalized medicine. The development of point-of-care testing devices and rapid diagnostic kits enhances accessibility and convenience, especially in remote and resource-limited settings. Integration of artificial intelligence and data analytics in diagnostic platforms improves accuracy and clinical decision-making. Additionally, growing investments in research and development, along with strategic collaborations between diagnostic companies and healthcare providers, are expected to create new avenues for growth. Expanding applications in oncology, infectious disease surveillance, and biomarker discovery further broaden the market scope.
Key Questions Answered in the Report:
- What are the primary factors driving the growth of the immunodiagnostics market globally?
- Which product types, technologies, and applications are driving adoption across different healthcare settings?
- How are technological advancements reshaping the competitive landscape of the immunodiagnostics market?
- Who are the key players contributing to the immunodiagnostics market, and what strategies are they employing to maintain market relevance?
- What are the emerging trends and future prospects in the global immunodiagnostics market?
Leading players in the global immunodiagnostics market, including Abbott, Roche Diagnostics, and Thermo Fisher Scientific, focus on innovation, product differentiation, and strategic partnerships to strengthen their market position. These companies invest heavily in research and development to introduce advanced diagnostic solutions with improved sensitivity, specificity, and turnaround time. Collaborations with healthcare providers, research institutions, and government agencies support technology adoption and market expansion. Additionally, emphasis on automation, digital integration, and expanding product portfolios helps companies remain competitive in the rapidly evolving diagnostic landscape.
Key Companies Profiled:
- Abbott
- Roche Diagnostics
- DiaSorin
- Danaher Corporation
- QIAGEN
- bioMérieux
- Thermo Fisher Scientific
- Quest Diagnostics
- Siemens Healthineers AG
- Bio-Rad Laboratories, Inc.
- Sysmex Corporation
- PerkinElmer, Inc.
- Agilent Technologies, Inc.
- Mindray Medical International Limited
- Grifols, S.A.
- Becton, Dickinson and Company (BD)
- Abcam plc
- Merck KGaA
- Enzo Biochem, Inc.
- Bio-Techne Corporation
- Meso Scale Diagnostics, LLC.
- GenScript Biotech Corporation
- Myriad Genetics, Inc.
- Others
By Product Type:
- Instruments
- Reagents and Consumables
- Enzyme-linked Immunosorbent Assay
- Chemiluminescence Immunoassay
- Fluorescent Immunoassay
- Radioimmunoassay
- Others
- Infectious Diseases
- Oncology and Endocrinology
- Bone and Mineral Diseases
- Autoimmunity Disorders
- Cardiac Biomarkers
- Drug Monitoring
- Others
- Clinical Laboratories
- Hospitals
- Physician’s Offices
- Others
- North America
- Europe
- East Asia
- South Asia and Oceania
- Latin America
- Middle East and Africa
Please Note: It will take 5 business days to complete the report upon order confirmation.
Table of Contents
199 Pages
- 1. Executive Summary
- 1.1. Global Immunodiagnostics Market Snapshot, 2025 and 2032
- 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
- 1.3. Key Market Trends
- 1.4. Future Market Projections
- 1.5. Premium Market Insights
- 1.6. Industry Developments and Key Market Events
- 1.7. PMR Analysis and Recommendations
- 2. Market Overview
- 2.1. Market Scope and Definition
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
- 2.3. Macro-economic Factors
- 2.3.1. Rising Prevalence of Chronic and Infectious Diseases Worldwide
- 2.3.2. Government Initiatives such as Screening Programs for HIV and Cancer
- 2.4. COVID-19 Impact Analysis
- 2.5. Forecast Factors - Relevance and Impact
- 3. Value Added Insights
- 3.1. Regulatory Landscape
- 3.2. Product Type Adoption Analysis
- 3.3. Key Deals and Mergers
- 3.4. PESTLE Analysis
- 3.5. Porter’s Five Force Analysis
- 4. Global Immunodiagnostics Market Outlook
- 4.1. Key Highlights
- 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
- 4.1.2. Absolute $ Opportunity
- 4.2. Market Size (US$ Bn) Analysis and Forecast
- 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
- 4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025-2032
- 4.3. Global Immunodiagnostics Market Outlook: Product Type
- 4.3.1. Introduction / Key Findings
- 4.3.2. Historical Market Size (US$ Bn) Analysis, By Product Type, 2019-2024
- 4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
- 4.3.3.1. Instruments
- 4.3.3.2. Reagents and Consumables
- 4.3.4. Market Attractiveness Analysis: Product Type
- 4.4. Global Immunodiagnostics Market Outlook: Technology
- 4.4.1. Introduction / Key Findings
- 4.4.2. Historical Market Size (US$ Bn) Analysis, By Technology, 2019-2024
- 4.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
- 4.4.3.1. Enzyme-linked Immunosorbent Assay
- 4.4.3.2. Chemiluminescence Immunoassay
- 4.4.3.3. Fluorescent Immunoassay
- 4.4.3.4. Radioimmunoassay
- 4.4.3.5. Others
- 4.4.4. Market Attractiveness Analysis: Technology
- 4.5. Global Immunodiagnostics Market Outlook: Application
- 4.5.1. Introduction / Key Findings
- 4.5.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2024
- 4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 4.5.3.1. Infectious Diseases
- 4.5.3.2. Oncology and Endocrinology
- 4.5.3.3. Bone and Mineral Diseases
- 4.5.3.4. Autoimmunity Disorders
- 4.5.3.5. Cardiac Biomarkers
- 4.5.3.6. Drug Monitoring
- 4.5.3.7. Others
- 4.5.4. Market Attractiveness Analysis: Application
- 4.6. Global Immunodiagnostics Market Outlook: End Use
- 4.6.1. Introduction / Key Findings
- 4.6.2. Historical Market Size (US$ Bn) Analysis, By End Use, 2019-2024
- 4.6.3. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2025-2032
- 4.6.3.1. Clinical Laboratories
- 4.6.3.2. Hospitals
- 4.6.3.3. Physician’s Offices
- 4.6.3.4. Others
- 4.6.4. Market Attractiveness Analysis: End Use
- 5. Global Immunodiagnostics Market Outlook: Region
- 5.1. Key Highlights
- 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
- 5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. East Asia
- 5.3.4. South Asia and Oceania
- 5.3.5. Latin America
- 5.3.6. Middle East & Africa
- 5.4. Market Attractiveness Analysis: Region
- 6. North America Immunodiagnostics Market Outlook
- 6.1. Key Highlights
- 6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 6.2.1. By Country
- 6.2.2. By Product Type
- 6.2.3. By Technology
- 6.2.4. By Application
- 6.2.5. By End Use
- 6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 6.3.1. U.S.
- 6.3.2. Canada
- 6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
- 6.4.1. Instruments
- 6.4.2. Reagents and Consumables
- 6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
- 6.5.1. Enzyme-linked Immunosorbent Assay
- 6.5.2. Chemiluminescence Immunoassay
- 6.5.3. Fluorescent Immunoassay
- 6.5.4. Radioimmunoassay
- 6.5.5. Others
- 6.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 6.6.1. Infectious Diseases
- 6.6.2. Oncology and Endocrinology
- 6.6.3. Bone and Mineral Diseases
- 6.6.4. Autoimmunity Disorders
- 6.6.5. Cardiac Biomarkers
- 6.6.6. Drug Monitoring
- 6.6.7. Others
- 6.7. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2025-2032
- 6.7.1. Clinical Laboratories
- 6.7.2. Hospitals
- 6.7.3. Physician’s Offices
- 6.7.4. Others
- 6.8. Market Attractiveness Analysis
- 7. Europe Immunodiagnostics Market Outlook
- 7.1. Key Highlights
- 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 7.2.1. By Country
- 7.2.2. By Product Type
- 7.2.3. By Technology
- 7.2.4. By Application
- 7.2.5. By End Use
- 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 7.3.1. Germany
- 7.3.2. France
- 7.3.3. U.K.
- 7.3.4. Italy
- 7.3.5. Spain
- 7.3.6. Russia
- 7.3.7. Turkey
- 7.3.8. Rest of Europe
- 7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
- 7.4.1. Instruments
- 7.4.2. Reagents and Consumables
- 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
- 7.5.1. Enzyme-linked Immunosorbent Assay
- 7.5.2. Chemiluminescence Immunoassay
- 7.5.3. Fluorescent Immunoassay
- 7.5.4. Radioimmunoassay
- 7.5.5. Others
- 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 7.6.1. Infectious Diseases
- 7.6.2. Oncology and Endocrinology
- 7.6.3. Bone and Mineral Diseases
- 7.6.4. Autoimmunity Disorders
- 7.6.5. Cardiac Biomarkers
- 7.6.6. Drug Monitoring
- 7.6.7. Others
- 7.7. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2025-2032
- 7.7.1. Clinical Laboratories
- 7.7.2. Hospitals
- 7.7.3. Physician’s Offices
- 7.7.4. Others
- 7.8. Market Attractiveness Analysis
- 8. East Asia Immunodiagnostics Market Outlook
- 8.1. Key Highlights
- 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 8.2.1. By Country
- 8.2.2. By Product Type
- 8.2.3. By Technology
- 8.2.4. By Application
- 8.2.5. By End Use
- 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 8.3.1. China
- 8.3.2. Japan
- 8.3.3. South Korea
- 8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
- 8.4.1. Instruments
- 8.4.2. Reagents and Consumables
- 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
- 8.5.1. Enzyme-linked Immunosorbent Assay
- 8.5.2. Chemiluminescence Immunoassay
- 8.5.3. Fluorescent Immunoassay
- 8.5.4. Radioimmunoassay
- 8.5.5. Others
- 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 8.6.1. Infectious Diseases
- 8.6.2. Oncology and Endocrinology
- 8.6.3. Bone and Mineral Diseases
- 8.6.4. Autoimmunity Disorders
- 8.6.5. Cardiac Biomarkers
- 8.6.6. Drug Monitoring
- 8.6.7. Others
- 8.7. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2025-2032
- 8.7.1. Clinical Laboratories
- 8.7.2. Hospitals
- 8.7.3. Physician’s Offices
- 8.7.4. Others
- 8.8. Market Attractiveness Analysis
- 9. South Asia & Oceania Immunodiagnostics Market Outlook
- 9.1. Key Highlights
- 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 9.2.1. By Country
- 9.2.2. By Product Type
- 9.2.3. By Technology
- 9.2.4. By Application
- 9.2.5. By End Use
- 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 9.3.1. India
- 9.3.2. Southeast Asia
- 9.3.3. ANZ
- 9.3.4. Rest of South Asia & Oceania
- 9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
- 9.4.1. Instruments
- 9.4.2. Reagents and Consumables
- 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
- 9.5.1. Enzyme-linked Immunosorbent Assay
- 9.5.2. Chemiluminescence Immunoassay
- 9.5.3. Fluorescent Immunoassay
- 9.5.4. Radioimmunoassay
- 9.5.5. Others
- 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 9.6.1. Infectious Diseases
- 9.6.2. Oncology and Endocrinology
- 9.6.3. Bone and Mineral Diseases
- 9.6.4. Autoimmunity Disorders
- 9.6.5. Cardiac Biomarkers
- 9.6.6. Drug Monitoring
- 9.6.7. Others
- 9.7. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2025-2032
- 9.7.1. Clinical Laboratories
- 9.7.2. Hospitals
- 9.7.3. Physician’s Offices
- 9.7.4. Others
- 9.8. Market Attractiveness Analysis
- 10. Latin America Immunodiagnostics Market Outlook
- 10.1. Key Highlights
- 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 10.2.1. By Country
- 10.2.2. By Product Type
- 10.2.3. By Technology
- 10.2.4. By Application
- 10.2.5. By End Use
- 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 10.3.1. Brazil
- 10.3.2. Mexico
- 10.3.3. Rest of Latin America
- 10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
- 10.4.1. Instruments
- 10.4.2. Reagents and Consumables
- 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
- 10.5.1. Enzyme-linked Immunosorbent Assay
- 10.5.2. Chemiluminescence Immunoassay
- 10.5.3. Fluorescent Immunoassay
- 10.5.4. Radioimmunoassay
- 10.5.5. Others
- 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 10.6.1. Infectious Diseases
- 10.6.2. Oncology and Endocrinology
- 10.6.3. Bone and Mineral Diseases
- 10.6.4. Autoimmunity Disorders
- 10.6.5. Cardiac Biomarkers
- 10.6.6. Drug Monitoring
- 10.6.7. Others
- 10.7. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2025-2032
- 10.7.1. Clinical Laboratories
- 10.7.2. Hospitals
- 10.7.3. Physician’s Offices
- 10.7.4. Others
- 10.8. Market Attractiveness Analysis
- 11. Middle East & Africa Immunodiagnostics Market Outlook
- 11.1. Key Highlights
- 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 11.2.1. By Country
- 11.2.2. By Product Type
- 11.2.3. By End Use
- 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 11.3.1. GCC Countries
- 11.3.2. Egypt
- 11.3.3. South Africa
- 11.3.4. Northern Africa
- 11.3.5. Rest of Middle East & Africa
- 11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
- 11.4.1. Instruments
- 11.4.2. Reagents and Consumables
- 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2025-2032
- 11.5.1. Enzyme-linked Immunosorbent Assay
- 11.5.2. Chemiluminescence Immunoassay
- 11.5.3. Fluorescent Immunoassay
- 11.5.4. Radioimmunoassay
- 11.5.5. Others
- 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
- 11.6.1. Infectious Diseases
- 11.6.2. Oncology and Endocrinology
- 11.6.3. Bone and Mineral Diseases
- 11.6.4. Autoimmunity Disorders
- 11.6.5. Cardiac Biomarkers
- 11.6.6. Drug Monitoring
- 11.6.7. Others
- 11.7. Current Market Size (US$ Bn) Analysis and Forecast, By End Use, 2025-2032
- 11.7.1. Clinical Laboratories
- 11.7.2. Hospitals
- 11.7.3. Physician’s Offices
- 11.7.4. Others
- 11.8. Market Attractiveness Analysis
- 12. Competition Landscape
- 12.1. Market Share Analysis, 2025
- 12.2. Market Structure
- 12.2.1. Competition Intensity Mapping By Market
- 12.2.2. Competition Dashboard
- 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 12.3.1. Abbott
- 12.3.1.1. Overview
- 12.3.1.2. Segments and Product Type
- 12.3.1.3. Key Financials
- 12.3.1.4. Market Developments
- 12.3.1.5. Market Strategy
- 12.3.2. Roche Diagnostics
- 12.3.3. DiaSorin
- 12.3.4. Danaher Corporation
- 12.3.5. QIAGEN
- 12.3.6. bioMérieux
- 12.3.7. Thermo Fisher Scientific
- 12.3.8. Quest Diagnostics
- 12.3.9. Siemens Healthineers AG
- 12.3.10. Bio-Rad Laboratories, Inc.
- 12.3.11. Sysmex Corporation
- 12.3.12. PerkinElmer, Inc.
- 12.3.13. Agilent Technologies, Inc.
- 12.3.14. Mindray Medical International Limited
- 12.3.15. Grifols, S.A.
- 12.3.16. Becton, Dickinson and Company (BD)
- 12.3.17. Abcam plc
- 12.3.18. Merck KGaA
- 12.3.19. Enzo Biochem, Inc.
- 12.3.20. Bio-Techne Corporation
- 12.3.21. Meso Scale Diagnostics, LLC.
- 12.3.22. GenScript Biotech Corporation
- 12.3.23. Myriad Genetics, Inc.
- 12.3.24. Others
- 13. Appendix
- 13.1. Research Methodology
- 13.2. Research Assumptions
- 13.3. Acronyms and Abbreviations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
